KAISHA Pharma establishes Kaisha Pharma International in Italy

Following the recent launch of Kaisha Pharma, the founders have taken the next strategic step in advancing their global customer-centric vision with the establishment of Kaisha Pharma International in Italy.

Kaisha Pharma International has been established as the company’s global business development and customer support hub, dedicated to spearheading strategic customer outreach, market interface and business development across overseas markets. From its base in Italy, the company will manage customer relationships and ensure customer support for its global pharmaceutical and biotechnology customers across the Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific, and other key international markets.

The establishment of Kaisha Pharma International follows the recent announcement of an initial €45 million capital deployment in Kaisha Pharma, as part of a multi-million-euro long-term investment programme, which is supporting the company’s global expansion strategy, advanced manufacturing capabilities, technology partnerships and the introduction of next-generation pharmaceutical packaging solutions.

The company also announced the appointment of Andrea Zambon as managing director of Kaisha Pharma International and global head of international business development.

“The establishment of Kaisha Pharma International marks another important milestone in our journey. When we launched Kaisha Pharma, our vision was clear: to build a truly Global pharmaceutical packaging company. Today’s announcement demonstrates that our commitment is already becoming a reality.”, said Kairus Dadachanji, managing director of Kaisha Pharma.

“Italy stands as one of the world’s most important pharmaceutical manufacturing and innovation centres. Establishing our global business development hub in the strategic location of Italy enables us to work even more closely with customers across the global pharmaceutical market while remaining responsive, accessible and internationally connected,” commented Rishad Dadachanji, the director of Kaisha Pharma.

“Equally important is the appointment of Andrea Zambon,” Dadachanji continued. “Andrea is widely respected within our industry and brings exceptional international experience, strategic leadership and customer focus. We are delighted to welcome him to Kaisha Pharma as we continue building a world-class global organisation.”

Commenting on his appointment, Andrea Zambon said, “I am honoured to join Kaisha Pharma at such an exciting stage of its development. The founders have created an ambitious vision built upon decades of experience, innovation and trust within the pharmaceutical packaging industry. What particularly attracted me to Kaisha Pharma is its determination not simply to participate in the market, but to help shape its future. Supported by significant long-term investment, advanced technologies and a genuine commitment to customer partnership, the company has all the ingredients necessary to become a globally respected player.”

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore